SCHEMBL3759318

SCHEMBL3759318

CC1(C)CNC(=O)c2sc(N3CCOCC3)c(-c3ccccc3)c2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.50
HIF1A Q16665 1/20 0.50
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
BRD4 O60885 1/20 0.39
HSD17B10 Q99714 2/20 0.38
HPGD P15428 1/20 0.38
PRKDC P78527 1/20 0.37
PIK3CA P42336 3/20 0.37
PIK3CD O00329 2/20 0.37
PIK3CB P42338 2/20 0.37
PIK3CG P48736 2/20 0.37
TSHR P16473 1/20 0.37
AR P10275 2/20 0.36
GRIA1 P42261 1/20 0.35
MAP2K2 P36507 1/20 0.35
MAP2K1 Q02750 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16161712 0.82 HTT (0.47) HTTHIF1AALDH1A1KDM4ESMN1; SMN2
SCHEMBL3756847 0.80 HTT (0.56) HTTHIF1AALDH1A1KDM4ESMN1; SMN2
SCHEMBL3762529 0.80 HTT (0.56) HTTHIF1ABRD4PIK3CAPIK3CD
SCHEMBL3760314 0.78 PIK3CD (0.42) HTTHIF1AALDH1A1SMN1; SMN2NPC1
SCHEMBL3758948 0.78 PIK3CD (0.42) ALDH1A1KDM4EBRD4HSD17B10HPGD
SCHEMBL3769513 0.76 GABRG2 (0.50) HTTHIF1AALDH1A1BRD4PIK3CA
SCHEMBL3755041 0.76 GABRA1 (0.53) HTTALDH1A1KDM4ESMN1; SMN2BRD4
SCHEMBL3761662 0.76 PRKDC (0.45) HTTHIF1AALDH1A1HSD17B10PRKDC
SCHEMBL3764482 0.75 BUB1 (0.44) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL3764589 0.75 BRD4 (0.43) ALDH1A1KDM4ESMN1; SMN2BRD4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA HTT 1234/4885HIF1A 2929/4885ALDH1A1 3061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.